NCT00736788View on ClinicalTrials.gov

Assess Safety, Tolerability and Pharmacokinetic (PK) of AZD1704 in Healthy Japanese Male and Non-Fertile Female Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Healthy Volunteers
Interventions
DRUG

AZD1704

single dose oral suspension, 4 different dose levels

DRUG

Placebo

single dose oral suspension

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY